Clinical Nuclear Medicine

Skip Navigation LinksHome > September 2012 - Volume 37 - Issue 9 > Recurrent Glioma and Crossed Cerebellar Diaschisis in a Pati...
Clinical Nuclear Medicine:
doi: 10.1097/RLU.0b013e318262af2a
Interesting Images

Recurrent Glioma and Crossed Cerebellar Diaschisis in a Patient Examined With 18F-DOPA and 18F-FDG PET/CT

Calabria, Ferdinando MD,*; Schillaci, Orazio MD*†

Free Access
Article Outline
Collapse Box

Author Information

From the *Department of Nuclear Medicine and Molecular Imaging, IRCCS Neuromed, Pozzilli (IS); and †Department of Biopathology and Diagnostic Imaging, University “Tor Vergata,” Rome, Italy.

Received for publication February 16, 2012; revision accepted May 30, 2012.

Conflicts of interest and sources of funding: none declared.

Reprints: Ferdinando Calabria, MD, Department of Nuclear Medicine and Molecular Imaging, IRCCS Neuromed, Via Atinense 18, 86077 Pozzilli (IS), Italy. E-mail: ferdinandocalabria@hotmail.it.

Collapse Box

Abstract

Abstract: Two years after resection of a left parietal glioma, a 46-year-old woman underwent 18F-FDG and 18F-DOPA brain PET/CT. FDG showed left parietal hypometabolism with crossed cerebellar diaschisis. No abnormally increased FDG activity was seen. 18F-DOPA PET/CT scan demonstrated focal left parietal uptake. Recurrent glioma was confirmed by surgical biopsy. 18F-DOPA may demonstrate abnormal amino acid metabolism in evaluation of recurrence of glioma.

Back to Top | Article Outline

REFERENCES

Figure 1
Figure 1
Image Tools
1. Tripathi M, Sharma R, Varshney R, et al.. Comparison of F-18 FDG and C-11 methionine for the evaluation of recurrent primary brain tumors. Clin Nucl Med. 2012; 37: 158–163.

2. Kanhaiya LA, Bhagwant RM, Anish B, et al.. Crossed cerebellar diaschisis on F-18 FDG PET/CT. Indian J Nucl Med. 2011; 26: 102–103.

3. Shih WJ, Huang WS, Milan PP. F-18 FDG PET demonstrates crossed cerebellar diaschisis 20 years after stroke. Clin Nucl Med. 2006; 31: 259–261.

4. Gonzalez-Forero M, Prieto E, Domingues I, et al.. Dual time point 18F-DOPA PET as a tool for characterizing brain tumors. Rev Esp Med Nucl. 2011; 30: 88–93.

5. Fueger BJ, Czernin J, Cloughesy T, et al.. Correlation of 6-18F-fluoro-L-DOPA PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas. Clin Nucl Med. 2011; 36: 650–655.

6. Tripathi M, Sharma R, D’Souza M, et al.. Comparative evaluation of F-18 FDOPA, F-18 FDG and F-18 FLT-PET/CT for metabolic imaging of low grade gliomas. Clin Nucl Med. 2009; 34: 878–883.

7. Santra A, Kumar R, Sharma P, et al.. Detection of recurrence in glioma: a comparative study between Tc-99m GHA SPECT and F-18 FDG PET/CT. Clin Nucl Med. 2011; 36: 650–655.

8. Chen W, Silverman DH, Delaloye S, et al.. 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy. J Nucl Med. 2006; 47: 904–911.

9. Ledezma CJ, Chen W, Sai V, et al.. 18F-DOPA PET/MRI fusion in patients with primary/recurrent gliomas: initial experience. Eur J Radiol. 2009; 71: 242–248.

10. Calabria F, Chiaravalloti A, Di Pietro B, et al.. Molecular imaging of brain tumors with 18F-DOPA PET and PET/CT. Nucl Med Commun. 2012; 33: 563–570.

Keywords:

18F-DOPA; 18F-FDG; PET/CT; brain tumor recurrence; crossed cerebellar diaschisis

© 2012 Lippincott Williams & Wilkins, Inc.

Login

Article Tools

Images

Share

Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.